v3.26.1
Derivative Instruments (Tables)
 12 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments Effect on Condensed Consolidated Statements of Operations
The following is the effect of derivative instruments on the Consolidated Statements of Operation for the years ended March 31, 2026, 2025, and 2024 (in thousands):
Derivatives Designated as Cash Flow  
Hedges		Type of InstrumentAmount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)Location of Gain or
(Loss) Recognized
in Income on
Derivatives		Amount of Gain or (Loss) Reclassified from AOCL into Income (Effective Portion)
March 31, 
2026Foreign exchange contracts$172 Cost of products sold$130 
2026Interest rate swap$171 Interest expense$839 
2026Cross currency swap$(1,497)Foreign currency exchange loss (gain)$(2,423)
2025Foreign exchange contracts$17 Cost of products sold$(27)
2025Interest rate swap$1,792 Interest expense$8,008 
2025Cross currency swap$434 Foreign currency exchange loss (gain)$(15)
2024Foreign exchange contracts$(168)Cost of products sold$(29)
2024Interest rate swap$7,145 Interest expense$9,739 
2024Cross currency swap$(70)Foreign currency exchange loss (gain)$502 
Schedule of Derivative Instruments
The following is information relative to the Company’s derivative instruments in the Consolidated Balance Sheets as of March 31, 2026 and 2025 (in thousands):
Fair Value of Asset (Liability)
March 31,
Derivatives Designated as
Hedging Instruments		March 31,20262025
Foreign exchange contractsPrepaid expenses and other$48 $139 
Foreign exchange contractsAccrued Liabilities(41)(188)
Interest rate swapPrepaid expenses and other596 597 
Interest rate swapOther Assets529 1 
Interest rate swapAccrued Liabilities(912)(99)
Interest rate swapOther non current liabilities(2,241)(1,639)
Cross currency swapAccrued liabilities(1,571)(49)
Cross currency swapOther non current liabilities(2,361)(1,800)